Impax Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-181,151
| Closed | -$14.7M | – | 199 |
|
2017
Q3 | $14.7M | Hold |
181,151
| – | – | 0.84% | 52 |
|
2017
Q2 | $12.8M | Sell |
181,151
-218
| -0.1% | -$15.4K | 0.72% | 65 |
|
2017
Q1 | $12.3M | Buy |
181,369
+10,002
| +6% | +$679K | 0.69% | 65 |
|
2016
Q4 | $12.3M | Buy |
171,367
+42,586
| +33% | +$3.05M | 0.7% | 68 |
|
2016
Q3 | $10.2M | Buy |
128,781
+35,772
| +38% | +$2.83M | 0.58% | 81 |
|
2016
Q2 | $7.76M | Sell |
93,009
-34,749
| -27% | -$2.9M | 0.45% | 90 |
|
2016
Q1 | $11.7M | Sell |
127,758
-57,396
| -31% | -$5.27M | 0.63% | 64 |
|
2015
Q4 | $18.7M | Buy |
185,154
+44,068
| +31% | +$4.46M | 1.04% | 34 |
|
2015
Q3 | $13.9M | Sell |
141,086
-21,630
| -13% | -$2.12M | 0.82% | 48 |
|
2015
Q2 | $19.1M | Sell |
162,716
-264
| -0.2% | -$30.9K | 1.02% | 33 |
|
2015
Q1 | $16M | Sell |
162,980
-67,457
| -29% | -$6.62M | 0.88% | 44 |
|
2014
Q4 | $21.7M | Sell |
230,437
-33,735
| -13% | -$3.18M | 1.29% | 27 |
|
2014
Q3 | $28.1M | Sell |
264,172
-59,225
| -18% | -$6.3M | 1.82% | 12 |
|
2014
Q2 | $26.8M | Sell |
323,397
-15,126
| -4% | -$1.25M | 1.69% | 15 |
|
2014
Q1 | $24M | Buy |
338,523
+136
| +0% | +$9.64K | 1.54% | 18 |
|
2013
Q4 | $25.4M | Buy |
338,387
+160,093
| +90% | +$12M | 1.61% | 16 |
|
2013
Q3 | $11.2M | Buy |
178,294
+101,339
| +132% | +$6.37M | 0.75% | 56 |
|
2013
Q2 | $3.94M | Buy |
+76,955
| New | +$3.94M | 0.27% | 84 |
|